Voss Capital LP Has $69.83 Million Holdings in Sotera Health Company $SHC

Voss Capital LP lifted its holdings in Sotera Health Company (NASDAQ:SHC) by 114.0% during the 4th quarter, HoldingsChannel reports. The fund owned 3,958,482 shares of the company’s stock after acquiring an additional 2,108,482 shares during the quarter. Sotera Health accounts for approximately 3.4% of Voss Capital LP’s holdings, making the stock its 11th largest position. Voss Capital LP’s holdings in Sotera Health were worth $69,828,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of SHC. Vanguard Group Inc. grew its stake in shares of Sotera Health by 16.7% in the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock valued at $339,189,000 after acquiring an additional 2,756,583 shares in the last quarter. Norges Bank acquired a new stake in Sotera Health during the fourth quarter worth approximately $45,278,000. Sculptor Capital LP grew its position in Sotera Health by 27.2% during the second quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock worth $127,880,000 after buying an additional 2,462,489 shares in the last quarter. Jennison Associates LLC acquired a new stake in Sotera Health during the fourth quarter worth approximately $24,720,000. Finally, Two Seas Capital LP grew its position in Sotera Health by 30.8% during the fourth quarter. Two Seas Capital LP now owns 4,412,106 shares of the company’s stock worth $77,830,000 after buying an additional 1,038,878 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SHC. Piper Sandler reissued an “overweight” rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Barclays reduced their price target on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. The Goldman Sachs Group began coverage on Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Finally, Citigroup increased their price target on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $20.29.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 15.36% of the company’s stock.

Sotera Health Trading Down 1.2%

Shares of SHC stock opened at $16.19 on Friday. The stock’s fifty day moving average price is $15.61 and its two-hundred day moving average price is $16.38. The company has a market cap of $4.62 billion, a PE ratio of 39.49 and a beta of 1.79. Sotera Health Company has a fifty-two week low of $10.80 and a fifty-two week high of $19.85. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company’s revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities analysts predict that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.